← Back to search

EVOTEC INTERNATIONAL GMBH

HAMBURG, 22419

Subcontracting experience

2 records from government sources. Past participation is not evidence of current teaming interest.

RoleAgencyDescriptionVehicleObligatedAction datePeriod
Subcontractor
Department of Health and Human Services
EVOTEC IS POISED TO START, UNDER CARB-X FUNDING, A NEW PROGRAM. THIS PROGRAM IS AT LEAD-TO-CANDIDATE STAGE AND AIMS AT DELIVERING AN IV-ADMINISTERED BROAD-SPECTRUM ANTIBACTERIAL DRUG CANDIDATE TO ADDRESS SEVERE HOSPITAL INFECTIONS CAUSED BY MULTI-DRUG RESISTANT (MDR) PATHOGENS. THE CORRESPONDING COMPOUNDS CONSTITUTE A NEW ANTIBACTERIAL CLASS THAT SIMULTANEOUSLY TARGETS TWO ESSENTIAL, WELL VALIDATED BACTERIAL ENZYMES. HOWEVER, THEY ACT BY A NEW MODE OF ACTION BECAUSE THEY BIND TO SITES THAT ARE NOT TARGETED BY CURRENTLY MARKETED ANTIBACTERIALS. THIS CLASS HAS SEVERAL BENEFICIAL PROPERTIES, INCLUDING A VERY BROAD-SPECTRUM OF BOTH GRAM-POSITIVE AND GRAM-NEGATIVE PATHOGENS, COVERING IN PARTICULAR MOST OF THE PROBLEMATIC MDR STRAINS. IN ADDITION, THE CLASS IS NOTED FOR ITS HIGH ANTIBACTERIAL POTENCY AND VERY LOW PROPENSITY TO SELECT RESISTANT STRAINS DUE TO THE UNIQUE DUAL-TARGETING MECHANISM. THE LEAD COMPOUNDS HAVE PERFORMED WELL IN EFFICACY AND SAFETY STUDIES. THE GOAL OF THE EVOTEC, CARB-X FUNDED PROGRAM IS TO COMPLETE THE OPTIMIZATION OF THE SERIES, IDENTIFY PRE-CANDIDATES AND ADVANCE THE MOST PROMISING COMPOUND INTO CLINICAL STUDIES. OVERALL, THIS NEW PROGRAM HAS POTENTIAL TO DELIVER TO THE CLINIC A NOVEL MODE OF ACTION, BROAD-SPECTRUM ANTIBACTERIAL DRUG, A MAJOR EVENT IN THE FIELD SINCE DECADES.
4500004468
Parent award context
Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
Parent award NAICS: 541714
Parent award performance state: MA
Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA
View parent award on USAspending
—$23,385May 25, 2023— – —
Subcontractor
Department of Health and Human Services
EVOTEC IS POISED TO START, UNDER CARB-X FUNDING, A NEW PROGRAM. THIS PROGRAM IS AT LEAD-TO-CANDIDATE STAGE AND AIMS AT DELIVERING AN IV-ADMINISTERED BROAD-SPECTRUM ANTIBACTERIAL DRUG CANDIDATE TO ADDRESS SEVERE HOSPITAL INFECTIONS CAUSED BY MULTI-DRUG RESISTANT (MDR) PATHOGENS. THE CORRESPONDING COMPOUNDS CONSTITUTE A NEW ANTIBACTERIAL CLASS THAT SIMULTANEOUSLY TARGETS TWO ESSENTIAL, WELL VALIDATED BACTERIAL ENZYMES. HOWEVER, THEY ACT BY A NEW MODE OF ACTION BECAUSE THEY BIND TO SITES THAT ARE NOT TARGETED BY CURRENTLY MARKETED ANTIBACTERIALS. THIS CLASS HAS SEVERAL BENEFICIAL PROPERTIES, INCLUDING A VERY BROAD-SPECTRUM OF BOTH GRAM-POSITIVE AND GRAM-NEGATIVE PATHOGENS, COVERING IN PARTICULAR MOST OF THE PROBLEMATIC MDR STRAINS. IN ADDITION, THE CLASS IS NOTED FOR ITS HIGH ANTIBACTERIAL POTENCY AND VERY LOW PROPENSITY TO SELECT RESISTANT STRAINS DUE TO THE UNIQUE DUAL-TARGETING MECHANISM. THE LEAD COMPOUNDS HAVE PERFORMED WELL IN EFFICACY AND SAFETY STUDIES. THE GOAL OF THE EVOTEC, CARB-X FUNDED PROGRAM IS TO COMPLETE THE OPTIMIZATION OF THE SERIES, IDENTIFY PRE-CANDIDATES AND ADVANCE THE MOST PROMISING COMPOUND INTO CLINICAL STUDIES. OVERALL, THIS NEW PROGRAM HAS POTENTIAL TO DELIVER TO THE CLINIC A NOVEL MODE OF ACTION, BROAD-SPECTRUM ANTIBACTERIAL DRUG, A MAJOR EVENT IN THE FIELD SINCE DECADES.
4500004468
Parent award context
Parent award agency: Department of Health and Human Services · Office of Assistant Secretary for Preparedness and Response
Parent award NAICS: 541714
Parent award performance state: MA
Parent award description: CARB-X GLOBAL ANTIBACTERIAL ACCELERATOR OTA
View parent award on USAspending
—$25,000Dec 22, 2022— – —

Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.

Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.

EVOTEC INTERNATIONAL GMBH – Hamburg | UEI LF5NR8KMJLG6 | FedSub